Correlation Between Scpharmaceuticals and Aravive
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Aravive at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Aravive into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Aravive, you can compare the effects of market volatilities on Scpharmaceuticals and Aravive and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Aravive. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Aravive.
Diversification Opportunities for Scpharmaceuticals and Aravive
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Scpharmaceuticals and Aravive is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Aravive in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aravive and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Aravive. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aravive has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Aravive go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Aravive
If you would invest 149.00 in Aravive on September 4, 2024 and sell it today you would earn a total of 0.00 from holding Aravive or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 0.4% |
Values | Daily Returns |
Scpharmaceuticals vs. Aravive
Performance |
Timeline |
Scpharmaceuticals |
Aravive |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Scpharmaceuticals and Aravive Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Scpharmaceuticals and Aravive
The main advantage of trading using opposite Scpharmaceuticals and Aravive positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Aravive can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aravive will offset losses from the drop in Aravive's long position.Scpharmaceuticals vs. Crinetics Pharmaceuticals | Scpharmaceuticals vs. Enanta Pharmaceuticals | Scpharmaceuticals vs. Amicus Therapeutics | Scpharmaceuticals vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |